KellyChinMD

Pulmonology • Dallas, TX

Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine

Physician

Join to view full profile

Dr. Chin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chin's full profile

Already have an account?

Office
5939 Harry Hines
Dallas, TX 75390
Phone+1 215-645-5505

Fax+1 214-645-5640

Education & Training

University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Texas Southwestern Medical SchoolClass of 1996

Certifications & Licensure

CA State Medical License 2002 - Present
TX State Medical License 2000 - 2026
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan Start of enrollment: 2009 Jan 01
Terminated
Phase 4
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension Start of enrollment: 2009 Sep 01
Completed
Phase 2
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies.
Kelly M Chin, Richard Channick, Nick H Kim, Gwen MacDonald, Rose Ong
Advances in Therapy. 2024-11-01
2 citations
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study.
Marc Humbert, Paul M Hassoun, Kelly M Chin, Guillermo Bortman, Mahesh J Patel
The European Respiratory Journal. 2024-11-01
10 citations
Treatment algorithm for pulmonary arterial hypertension.
Kelly M Chin, Sean P Gaine, Christian Gerges, Zhi-Cheng Jing, Stephen C Mathai
The European Respiratory Journal. 2024-10-01